Virax Biolabs Group Limit... (VRAX)

1.09

0.07 (6.86%)

At close: Apr 24, 2025, 3:57 PM

1.08

-0.92%

After-hours: Apr 24, 2025, 07:36 PM EDT

Virax Biolabs Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	-6.74M	-5.46M	-1.71M	-650.98K	-739.46K
Depreciation & Amortization	103.1K	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.01M	1.73M	290.36K	n/a	n/a
Other Working Capital	-269.56K	-237.23K	2.19K	0.00	n/a
Other Non-Cash Items	497.06K	-260.6K	-32.07K	1.19K	91.67K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.12M	-216.28K	644.39K	59.61K	-96.82K
Operating Cash Flow	-6.25M	-4.18M	-809.07K	-590.19K	-744.61K
Capital Expenditures	-1.16M	-178.4K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-211.95K	-178.4K	n/a	n/a	n/a
Investing Cash Flow	-1.16M	-178.4K	n/a	n/a	n/a
Debt Repayment	-206.27K	146.25K	100K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.85M	-111.64K	193.59K	585.2K	704.64K
Financial Cash Flow	1.65M	13.69M	813.21K	585.2K	704.64K
Net Cash Flow	-5.76M	9.33M	4.13K	-4.99K	-39.97K
Free Cash Flow	-7.41M	-4.36M	-809.07K	-590.19K	-744.61K